2000
The Lyme disease vaccine: conception, development, and implementation.
Thanassi W, Schoen R. The Lyme disease vaccine: conception, development, and implementation. Annals Of Internal Medicine 2000, 132: 661-8. PMID: 10766685, DOI: 10.7326/0003-4819-132-8-200004180-00009.Peer-Reviewed Original Research
1998
Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
Steere A, Sikand V, Meurice F, Parenti D, Fikrig E, Schoen R, Nowakowski J, Schmid C, Laukamp S, Buscarino C, Krause D. Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant. New England Journal Of Medicine 1998, 339: 209-215. PMID: 9673298, DOI: 10.1056/nejm199807233390401.Peer-Reviewed Original ResearchConceptsLyme diseaseSerologic testingVaccine efficacyAsymptomatic infectionLipoprotein AInjections of vaccineOuter surface lipoprotein AB. burgdorferi infectionFirst yearPlacebo recipientsPlacebo groupVaccine groupVaccine recipientsStudy entryRandomized trialsSystemic reactionsThird injectionBurgdorferi infectionEffective vaccineSkin lesionsReaction testingVaccineDefinite casesDiseaseInfection
1992
Failure of Multitarget Detection of Borrelia Burgdorferi—Associated DNA Sequences in Synovial Fluids of Patients with Juvenile Rheumatoid Arthritis: a Cautionary Note
Malawista S, Schoen R, Moore T, Louis, Dodge D, White T, Persing D. Failure of Multitarget Detection of Borrelia Burgdorferi—Associated DNA Sequences in Synovial Fluids of Patients with Juvenile Rheumatoid Arthritis: a Cautionary Note. Arthritis & Rheumatism 1992, 35: 246-248. PMID: 1734914, DOI: 10.1002/art.1780350220.Peer-Reviewed Original Research